ACA
Overvalued by 4.3% based on the discounted cash flow analysis.
Market cap | $4.28 Billion |
---|---|
Enterprise Value | $4.71 Billion |
Dividend Yield | $0.1998 (0.23%) |
Earnings per Share | $2.93 |
Beta | 1.16 |
Outstanding Shares | 48,582,544 |
Avg 30 Day Volume | 283,032 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 29.99 |
---|---|
PEG | -101.49 |
Price to Sales | 1.86 |
Price to Book Ratio | 1.86 |
Enterprise Value to Revenue | 2 |
Enterprise Value to EBIT | 26.32 |
Enterprise Value to Net Income | 33 |
Total Debt to Enterprise | 0.13 |
Debt to Equity | 0.26 |
No data
No data